Developing Product Liability Index for Korean Manufacturing Companies
نویسندگان
چکیده
منابع مشابه
Product innovation in UK manufacturing companies
BIOGRAPHICAL NOTES Keith Goffin graduated from Durham University in 1977 with a first class honours degree in Physics and subsequently obtained a masters in Medical Physics from Aberdeen University. In 1980 he joined the Medical Products Group of Hewlett-Packard (HP) in Germany as an engineer working on new product development. Later, he held various management roles including Product Marketing...
متن کاملDeveloping Environmental Thinking in Manufacturing Companies
This paper presents the development of a process for manufacturing companies to facilitate environmental thinking for the integration of environmental concerns into their business operations. The process takes its point of departure in Corporate Social Responsibility while maintaining focus on obtaining direct benefits for the business. By understanding the end-uses’ perception, drivers, limita...
متن کاملEVA for Small Manufacturing Companies
This paper examines introducing Economic Value Added as a performance measure for small manufacturing companies. Advantages and disadvantages of using Economic Value Added as a primary measure of performance as compared to sales, revenues, earnings, operating profit, profit after tax, and profit margin are investigated. The Economic Value Added calculation using data from a small company’s inco...
متن کاملProduct liability.
Product liability litigation has made important contributions to tobacco control, especially by uncovering incriminating industry documents and publicizing product dangers and industry misconduct. WHO Framework Convention on Tobacco Control (FCTC) Article 19 encourages Parties to strengthen legal procedures to facilitate these lawsuits and to establish mechanisms for mutual assistance. Creative...
متن کاملPharmaceutical Product Liability
Product liability is one of the fastest growing and most economically significant applications of tort law. Product liability actions against pharmaceutical companies are among the most widely publicized classes of suits in the United States and Europe, prompting pharmaceutical companies to lobby vigorously for tort reform. (Nace et al., 1997). The liability burden on pharmaceutical companies h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Quality Innovation Prosperity
سال: 2017
ISSN: 1338-984X,1335-1745
DOI: 10.12776/qip.v21i2.877